Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
November 5, 2018
Aileron Therapeutics Appoints Vojislav Vukovic, MD, PhD, as Chief Medical Officer
WATERTOWN, Mass., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (ALRN), the clinical stage leader in the field of stabilized, cell-permeating peptides to treat cancer ...
November 1, 2018
AC Immune to Present at 2018 Society for Neurosciences Meeting
Lausanne, Switzerland, November 1, 2018 - AC Immune SA (ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases will provide ...
November 1, 2018
Arrowhead Pharmaceuticals to Present at Upcoming November 2018 Conferences
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it is scheduled to present at the following upcoming events: BIT’s 16th Annual Congress of International ...
November 1, 2018
AzurRx BioPharma Receives Sanction of Cystic Fibrosis Therapeutics Development Network for the Study of MS1819-SD in CF Patients with EPI
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies ...
November 1, 2018
Spring Bank Announces Three Poster Presentations on Its Next-Generation STING Agonist Program at the AACR Special Conference on Tumor Immunology and Immunotherapy
HOPKINTON, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
November 1, 2018
Zogenix to Release Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 8
EMERYVILLE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
November 1, 2018
MannKind Corporation Reports 2018 Third Quarter Financial Results
WESTLAKE VILLAGE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) today reported financial results for the third quarter ended September 30, 2018. ...
November 1, 2018
Catalyst Biosciences Reports Third Quarter Operating & Financial Results and Provides a Corporate Update
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announced operating and financial results for the third quarter ending ...
November 1, 2018
Aimmune Therapeutics to Participate in Upcoming Investor Conferences
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that members of senior management will participate in ...
November 1, 2018
BioLineRx to Report Third Quarter 2018 Results on November 8, 2018
TEL AVIV, Israel, November 1, 2018 /PRNewswire/ --BioLineRx Ltd. (BLRX) (BLRX.TA), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today it will release ...
November 1, 2018
Opiant Pharmaceuticals to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on Wednesday, November 7th
SANTA MONICA, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug ...
November 1, 2018
Miragen Therapeutics to Present New Cobomarsen Phase 1 Clinical Trial Data at the 2018 American Society of Hematology Annual Meeting
BOULDER, Colo., Nov. 01, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, ...
November 1, 2018
Bispecific GD2 Antibody In Vivo Data to be Presented at ASH
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (YMAB), a late-stage clinical biopharmaceutical company focused on the development ...
November 1, 2018
Celyad to Present New CYAD-01 Data from THINK Study in Relapsed/Refractory Acute Myeloid Leukemia at 2018 ASH Annual Meeting
MONT-SAINT-GUIBERT, Belgium, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
November 1, 2018
Sierra Oncology to Report Clinical Data at ASH 2018 from Translational Biology Study of Momelotinib in Transfusion Dependent Patients
VANCOUVER, Nov. 1, 2018 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of ...
October 31, 2018
Orchard Therapeutics Announces Pricing of Initial Public Offering
BOSTON and LONDON, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics plc (ORTX), a biopharmaceutical company dedicated to transforming the lives of patients with serious ...
October 31, 2018
CytoSorbents to Report Q3 2018 Operating and Financial Results
MONMOUTH JUNCTION, N.J., Oct. 31, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and ...
October 31, 2018
ProQR Announces Presentations at the European Oligonucleotide and Peptide Therapeutics Conference
LEIDEN, the Netherlands and CAMBRIDGE, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation ...
October 31, 2018
Arrowhead Pharmaceuticals Announces Closing of Agreements with Janssen
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that the license agreement and research collaboration and option agreement between Arrowhead and Janssen Pharmaceuticals, Inc., part ...
October 31, 2018
HTG Molecular Appoints Dr. Maureen T. Cronin as Chief Scientific Officer and Senior Vice President
TUCSON, Ariz., Oct. 31, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today ...
Page 40 of 150